Randomized controlled trials provide important evidence to guide clinical practice.
| INTRODUCTION
Rigorously conducted randomized controlled trials (RCTs) provide important evidence to guide clinical and policy decisions about medical interventions. Phase III studies, often enrolling thousands of patients, provide high quality evidence about the efficacy and safety of a drug or device, 1 and are needed before regulatory agencies, clinicians, guideline developers, and policymakers confidently adopt or reject a health intervention. Phase III randomized trials need to be well designed and implemented to yield valid conclusions. 2 Conversely, those that are poorly designed and implemented are inefficient and wasteful, and may be unethical and jeopardize patient safety.
Conducting full-scale clinical trials is an expensive and timeconsuming process. In the current research environment, with increased recognition of research waste 3 and growing accountability and competition for research funding, granting agencies look favorably on pilot data demonstrating the feasibility of recruitment, procedures and methods, and field testing the logistical aspects of a large trial on a smaller scale.
| What is a pilot trial?
A pilot trial is a small study conducted to help design and assess the feasibility of doing a larger, full-scale trial. They also investigate whether the methods and procedures are able to obtain the data that is needed to answer the question that will be addressed in the larger study. 4 Currently, there is a lack of consistency in the terms used to refer to a study aimed at assessing the feasibility of a large phase III RCT (Box 1) and this topic is the focus of a detailed report and conceptual framework. 5 In this framework, feasibility studies include: randomized pilot studies, in which the future RCT is conducted on a smaller scale ("piloted"); nonrandomized pilot studies in which the intervention and other study processes are tested, and feasibility studies that develop processes that will be used in a future full-scale trial (eg, gathering information through interviews or questionnaires) but do not pilot the processes or interventions of the future trial. Eldridge et al. conclude that the interchangeable use of various terms seems acceptable to use for a randomized study with a primary aim of assessing the feasibility of a future full-scale RCT 6 ; they recommend that in the title and abstract, the study be clearly identified by using the words pilot or feasibility, along with the terms randomized and trial. This paper focuses on randomized pilot studies and we refer to them as pilot trials.
There are many misconceptions about pilot trials. As highlighted by Thabane et al., studies performed as a research project by a trainee, or on a small scale at a single center because of lack of funding, should not be referred to as "pilot studies" if their aim is not to inform larger-scale studies. 4 This misuse of terminology could account for the fact that only 50% of pilot studies identified in a systematic review reported the intention of future work, and only a small minority (<10%) were actually followed by a large study. 7 In this paper we describe the conception, design, and ini- 
| METHODS

| Objectives and outcomes
As described above, a defining feature of pilot trials is that the primary aim is to determine feasibility of a large full-scale trial. Consequently, regardless of the full-scale trial's design or methods, the objectives of the pilot trial are focused on feasibility and the methodology of the pilot trial is tailored to these feasibility-focused objectives. A common error is for the objectives of a pilot trial to be either unclear or stated as being identical to the large RCT. 8 In Table 1 we provide examples of the types of objectives that are suitable for pilot trials and fullscale trials.
| Sample size determination
Sample size for a pilot trial is based on the pilot trial's objectives, outcomes, and analysis plan, depending on whether the primary outcome is a proportion, binary, ordinal, or continuous outcome. In contrast, for phase III full-scale trials, the sample size is calculated based on the desired statistical power, accepted type 1 error (alpha risk), expected effect size (minimal clinically important difference), and the variability of the outcome measure.
From an audit of sample sizes in pilot and feasibility studies registered in the UK Clinical Research Network database, authors conclude that even though sample size calculations are not a requirement for pilot trials, all pilot trials should have a sample size justification which states the rationale for the target sample size. 9 Further, they stress that due to the high level of uncertainty in a pilot study, the target sample size should be considered a preliminary figure.
In the examples of sample size rationale statements provided in the CONSORT extension to randomized pilot and feasibility trials, this uncertainty is reflected in the use of the words "estimated" and "aimed for." 6 It is tempting to follow one of the "rules of thumb" that have been suggested for pilot trials, such as using a minimum sample size of 12 per group, 50 per group, or corresponding to at least 3% of the sample size of the full-scale trial. 9 Thabane et al. suggest using a confidence interval approach to determine sample size when the objective of the study is to assess feasibility as reflected by a proportion (eg, proportion of screened patients who are eligible and consenting). 4 The pilot study should then include enough patients to ensure that the lower bound of the 95% confidence interval around the estimate of this proportion exceeds the preset value for feasibility. 4 While these rules are based on statistical theory and modelling, it is essential that investigators are conscious of the situation (eg, type of outcome and analysis) for which the rule is intended and not apply a rule indiscriminately. 
| TRIM-Line sample size justification
| Statistical analysis
Similar to phase III trials, pilot studies should have clearly identified outcomes, corresponding to their feasibility objectives. The analysis should focus on these objectives, and results interpretation should be based on prespecified criteria for success. These criteria will lead to the determination of whether the full-scale RCT is feasible, may be feasible with modification, or is not feasible. Although the outcome measures that will be used for the full-scale RCT may be looked at, they should not be the primary focus. By their nature, pilot trials will be underpowered to compare the primary outcome of the full trial. Further, if the intention from the outset is to pool the data from patients enrolled in the pilot trial with data from patients in the full-scale RCT, this should be specified in the pilot trial's protocol and should include data merging and analysis plans, along with statistical consequences for the main trial. Pilot trial results are worth publishing as they inform the research community on the feasibility (or lack of) of the intended RCT, identify feasibility barriers, and may suggest solutions to these obstacles. 
| The TRIM-Line pilot trial's methods
| DISCUSSION
The CanVECTOR network is supportive of pilot trials and considers them to be valuable. This commitment to funding pilot trials is based on the belief that pilot trials prevent research waste through identifying barriers to full-scale trial feasibility at modest expense. In addition to the formal analyses in a pilot trial, there's an opportunity for qualitative observations that can be taken into consideration when planning the full-scale trial, such as feedback from colleagues and patients, noted barriers or delays to start-up or recruitment, and trends in recruitment such as slow initial recruitment that increases over the first months before reaching a steady state. 
| Importance of mentorship and a team approach
Mentorship is crucial to the success of clinician scientists during their training and early research career 12 (Box 2). Mentorship has been found to increase research productivity, increase the confidence of mentees and provide opportunities for professional networking. 13 Conducting a pilot trial is complex and requires 
Box 2 Benefits of mentorship to early career investigators
Higher likelihood to continue in a research career 14, 15 Increased confidence and preparedness to pursue a research career 16 Greater research productivity and grant success 13, [17] [18] [19] Additional opportunities for networking and collaboration 16 Better overall satisfaction 13, 18, 20 early career investigators, and facilitates the sharing of examples (eg, successful funding application, pilot trial protocol, consent form) or tools (eg, data capture form, study start-up checklist) with less experienced researchers.
| Budget considerations for a pilot trial
A common misconception is that a lack of resources for a large multicenter trial justifies doing a pilot trial. 4 
| TRIM-Line budget
The 
| Publishing a pilot trial
Early reviews found that the quality of published pilot trials was poor 21 and journal editors cited lack of rigor as a reason that they did not publish pilot trial results. 7 However, even if a pilot trial finds that a full-scale trial is nonfeasible, this is an important finding that should be published so that other investigators may benefit from this extension to randomized pilot and feasibility studies." 6 Particularly,
there is a greater focus on the recruitment process, including initial screening to identify subjects who meet inclusion criteria, assessment of exclusions in those who meet inclusion criteria, and rate and reasons that study-eligible patients do not consent to participate. In the extended statement, less emphasis is placed on describing procedures such as randomization, allocation concealment, and blinding, unless the objectives of the pilot trial specifically relate to these topics.
However, providing the registration number for the pilot trial in a trial registry, information about where the pilot trial protocol can be accessed, and confirming that the pilot trial has received ethics approval are all recommended. The rationale for registration of a pilot trial is the same as that of the full-scale trial: it will inform other researchers of work in progress, thus preventing duplication, and can improve accountability for reporting results of the pilot trial by allowing others to more easily assess for selective outcome reporting or changes in the design or outcomes. The CONSORT 2010 extension to randomized pilot and feasibility trials includes a side-by-side comparison of the checklist of items to include when reporting an RCT and a pilot trial (their Table 2 ). 6 In summary, a positive pilot trial can provide strong support for a granting agency to fund a full-scale trial, but a negative pilot trial is also important and should be published so that it can lead to changes in the design of an RCT or prevent scarce resources from being wasted. 
